Dr. Linenberger cares for people who have anemia, bleeding and thrombotic disorders, low platelets, sickle cell disease, iron overload, myeloma, leukemia, lymphoma, myelodysplasia and myeloproliferative disorders.
I strive to provide compassionate care by forming a partnership with the patient and other providers. In delivering this care, we utilize the skills and knowledge base of the entire university medical community.
Therapeutic apheresis; marrow and peripheral blood stem cell procurement; AML treatment with antibody-based agents; hypercoagulable disorders; iron overload disorders; porphyrias; benign and malignant hematologic disorders.
- Medical Director, Apheresis and Cellular Therapy, Seattle Cancer Care Alliance
- Full Member, Clinical Research Division, Fred Hutchinson Cancer Research Center
- Professor, Hematology, University of Washington School of Medicine
- Program Director, Hematology-Oncology Fellowship, University of Washington School of Medicine
- Robert and Phyllis Henigson Endowed Chair, University of Washington School of Medicine
- MD: University of Kansas, Medicine, 1982
- Residency: Rhode Island Hospital (Brown University), Internal Medicine, 1985
- Fellowship: University of Washington, Hematology, 1989
- Dr. Linenberger was recognized in 2012, 2014, 2015 and 2016 as a "Top Doctor" in Seattle magazine's annual survey.
- For more information about Dr. Michael L. Linenberger's clinical and research expertise, click here.
An early interest in cell biology sparked Dr. Michael Linenberger’s interest in a medical career. He grew up in rural Kansas and was a self-professed science nerd with a love of microscopy. Though he planned to follow the primary care path, his discovery of the complexities of hematology steered him toward this specialty. Putting his passion to use during a fellowship and his early academic career at the University of Washington (UW), he engaged in research that included investigations of blood cell development, stem cell biology, and drug-resistance mechanisms in acute leukemia.
At the Seattle Cancer Care Alliance Hematology Clinic, as well as the SCCA Inpatient Hospital at UW Medical Center, Dr. Linenberger cares for patients who have disorders ranging from anemia and sickle cell disease to bleeding and thrombotic disorders to leukemia, lymphoma, and myeloproliferative disorders. In 2005, he received the Fred Hutchinson Cancer Research Center Clinical Research Division’s Ali Johany Prize for excellence in patient care.
Since joining the UW School of Medicine faculty, Dr. Linenberger has taken an active role in education. He is the Robert and Phyllis Henigson Professor of Hematology and serves as the program director of the Hematology/Oncology Fellowship Program.
Dr. Linenberger is both the medical director of the National Marrow Program collection center at SCCA and of Apheresis and Cellular Therapy at SCCA. Apheresis is a specialized process to collect stem cells for transplantation.
When he isn’t taking care of patients, teaching, or conducting research, Dr. Linenberger and his wife, who is a family practitioner, enjoy traveling and sea kayaking.